LRP10 in α-synucleinopathies

LRP10 in α-synucleinopathies

Bibliografiset tiedot
Päätekijät:	Guerreiro, R, Orme, T, Neto, JL, Bras, J, Parkkinen, L, Ansorge, O
Muut tekijät:	International DLB Genetics Consortium
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Elsevier 2018

Samankaltaisia teoksia

Selective vulnerability in α-synucleinopathies.
Tekijä: Alegre-Abarrategui, J, et al.
Julkaistu: (2019)

Autonomic Dysfunction in α-Synucleinopathies
Tekijä: José Javier Mendoza-Velásquez, et al.
Julkaistu: (2019-04-01)

Autophagy in α-Synucleinopathies—An Overstrained System
Tekijä: Lisa Fellner, et al.
Julkaistu: (2021-11-01)

Immunotherapies in Huntington's disease and α-Synucleinopathies
Tekijä: Oluwaseun Fatoba, et al.
Julkaistu: (2020-02-01)

Insular monoaminergic deficits in prodromal α‐synucleinopathies
Tekijä: Andrea Pilotto, et al.
Julkaistu: (2024-11-01)

Leukotriene Signaling as a Target in α-Synucleinopathies
Tekijä: Katharina Strempfl, et al.
Julkaistu: (2022-02-01)

Can olfactory bulb biopsy be justified for the diagnosis of Parkinson’s disease? Comments on “olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders”
Tekijä: Parkkinen, L, et al.
Julkaistu: (2008)

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
Tekijä: Chao Peng, et al.
Julkaistu: (2018-01-01)

α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies
Tekijä: Hazem Abdelkarim, et al.
Julkaistu: (2018-08-01)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Tekijä: Inês C. Brás, et al.
Julkaistu: (2021-02-01)

α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
Tekijä: Matthias Schmitz, et al.
Julkaistu: (2023-03-01)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
Tekijä: Alessandra Bigi, et al.
Julkaistu: (2023-01-01)

Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
Tekijä: Junghwan Shin, et al.
Julkaistu: (2020-01-01)

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
Tekijä: Miguel Lemos, et al.
Julkaistu: (2020-09-01)

Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
Tekijä: Sarkar, Souvarish, et al.
Julkaistu: (2021)

Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
Tekijä: Sarkar, Souvarish, et al.
Julkaistu: (2022)

Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
Tekijä: Souvarish Sarkar, et al.
Julkaistu: (2020-12-01)

α-Synuclein pathology in post-mortem retina and optic nerve is specific for α-synucleinopathies
Tekijä: Frederique J. Hart de Ruyter, et al.
Julkaistu: (2023-08-01)

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
Tekijä: Irina Alecu, et al.
Julkaistu: (2019-04-01)

Parkinson's Disease and Mitotherapy-Based Approaches towards α-Synucleinopathies
Tekijä: Vidhi Bhatt, et al.
Julkaistu: (2024-05-01)

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
Tekijä: Gaia Codolo, et al.
Julkaistu: (2013-01-01)

Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathy
Tekijä: Scott C. Vermilyea, et al.
Julkaistu: (2022-07-01)

Il-10 signaling reduces survival in mouse models of synucleinopathy
Tekijä: Samuel G. Cockey, et al.
Julkaistu: (2021-03-01)

Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons
Tekijä: Emily M. Rocha, et al.
Julkaistu: (2015-10-01)

Solubility of α-synuclein species in the L62 mouse model of synucleinopathy
Tekijä: Karima Schwab, et al.
Julkaistu: (2024-03-01)

Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease
Tekijä: Sean J. Miller, et al.
Julkaistu: (2022-04-01)

Gut Microbiome-Modified Polyphenolic Compounds Inhibit α-Synuclein Seeding and Spreading in α-Synucleinopathies
Tekijä: Tritia R. Yamasaki, et al.
Julkaistu: (2020-05-01)

Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
Tekijä: Grace Kuo, et al.
Julkaistu: (2025-01-01)

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
Tekijä: Parkkinen, L, et al.
Julkaistu: (2016)

Investigating brain-derived α-synuclein fibrils and diagnostic biomarkers of synucleinopathies
Tekijä: Lee, S
Julkaistu: (2023)

Network disruption based on multi-modal EEG-MRI in α-synucleinopathies
Tekijä: Chunyi Wang, et al.
Julkaistu: (2024-08-01)

α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
Tekijä: Simon Oliver Hoppe, et al.
Julkaistu: (2021-06-01)

Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?
Tekijä: Arati Tripathi, et al.
Julkaistu: (2021-12-01)

Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy
Tekijä: Peng Wang, et al.
Julkaistu: (2021-09-01)

Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy
Tekijä: Ichiro Kawahata, et al.
Julkaistu: (2022-02-01)

Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
Tekijä: Nahuai Badiola, et al.
Julkaistu: (2011-01-01)

Lovastatin Alleviates α-Synuclein Aggregation and Phosphorylation in Cellular Models of Synucleinopathy
Tekijä: Lijun Dai, et al.
Julkaistu: (2021-07-01)

LAG3 is not expressed in human and murine neurons and does not modulate α‐synucleinopathies
Tekijä: Marc Emmenegger, et al.
Julkaistu: (2021-07-01)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
Tekijä: Hao Gu, et al.
Julkaistu: (2021-03-01)

Inflammation and heterogeneity in synucleinopathies
Tekijä: Antoine Freuchet, et al.
Julkaistu: (2024-08-01)